<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15207-bib-0058">
 <mixed-citation publication-type="journal" id="bph15207-cit-0059">
  <string-name>
   <surname>Luo</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Qiu</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>X.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>D.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Li</surname>, 
   <given-names>J.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Tocilizumab treatment in COVID‐19: A single center experience</article-title>. 
  <source xml:lang="en">Journal of Medical Virology</source>, 
  <volume>92</volume>(
  <issue>7</issue>), 
  <fpage>814</fpage>–
  <lpage>818</lpage>. 
  <pub-id pub-id-type="doi">10.1002/jmv.25801</pub-id>
  <pub-id pub-id-type="pmid">32253759</pub-id>
 </mixed-citation>
</ref>
